Sign in
4

Changes in Ownership

PTC THERAPEUTICS, INC. Filed Acc 0001415889-25-021130

CHIEF EXECUTIVE OFFICER sold 10,739 shares at $51.74 ($555,636)

  • CHIEF EXECUTIVE OFFICER acquired 75,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Klein Matthew B. · CHIEF EXECUTIVE OFFICER

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-01 Grant or award : show line 1 in the form 10b5-1 +75,000 348,506 D
2025-08-05 Sale : show line 2 in the form 10b5-1 −10,739 $51.74 $555,636 337,767 D
Open-market sales · 10,739 sh · avg $51.74 · $555,636
Loading xslF345X05/form4-08052025_080801.xml…